.jpeg)
英菲格拉替尼2022价格,多少钱一盒？
How much will Infigratinib cost in 2022?
Infigratinib is responsible for clinical research and commercialization in China and other major Asian markets. It is a globally innovative targeted drug for cholangiocarcinoma. In December 2021, it was the first to land in the Boao Lecheng International Medical Tourism Pilot Zone and issued its first prescription at Hainan Lecheng Boao Super Hospital. However, it has not yet been officially launched in China, and there is no domestic price information for infigratinib.
It is understood that infigratinib was approved by the US FDA on May 29, 2021 for the treatment of cholangiocarcinoma, mainly targeting cholangiocarcinoma with FGFR2 fusion gene mutations. It is understood that the price of Infigratinib in overseas markets is about 219,600 per box, but due to exchange rate fluctuations, the price of the drug is not fixed.
How much does Infigratinib cost per month?
The dosage of Infigratinib is 125 mg, taken orally once a day, for 21 days of continuous use and 7 days of drug withdrawal, with a 28-day treatment cycle. The specification of Infigratinib is 125mg*21 tablets, which means that you need at least one box of this product a month, and the cost is about 219,600.
Patients in need can go abroad to purchase Infigratinib, or they can obtain it through domestic professional overseas medical service institutions. The medicine can be directly mailed to their homes from overseas. It is guaranteed to be genuine and affordable at the same time. With a drug purchase contract signed, patients are more secure when purchasing medicine.
Infigratinib is an oral FGFR1-3 selective inhibitor that blocks downstream signaling cascades by selectively binding and inhibiting FGFR activity, reducing cancer cell proliferation and inducing tumor cell death. Infigratinib can be continued to be administered until the disease progresses or unacceptable toxicity occurs. Patients are advised to follow the doctor's instructions and receive symptomatic treatment.
Recommended related articles:
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
